In May Mission Street and BGO ran a photography competition entitled ‘Tomorrow’s World’ for students and alumni. The response was fantastic with over 200 images submitted showcasing a highly broad interpretation of the theme! Ten images have been shortlisted and professionally framed and hung at Inventa, Oxford, significantly enhancing the arrival experience. A huge thank […]
Specialist innovation real estate platform Mission Street and investor BGO have signed leading biotech firm Nucleome Therapeutics for 20,000 sq ft on a 10-year lease at Inventa, central Oxford’s first purpose-built commercial science scheme Nucleome is relocating its HQ from Oxford Science Park High-growth company has received backing from Oxford Science Enterprises and blue-chip investors […]
Mission Street and BGO’s Inventa and Fabrica will be the first Sciences developments of a wider 2.5m sq ft pipeline of academic and commercial Science buildings creating the only Innovation District within walking distance of Oxford station and Oxford city’s world class academic, cultural and amenity offerings. https://oxfordwestend.co.uk/discover/
Artem Korolev discussed how to nurture and facilitate a world-class innovation system. https://www.youtube.com/watch?v=jL-16hnWVTw&list=PLRIcKUhnlDtg92I1zL24mHMkGHQLxb3tH&index=12&t=353s
Mission Street and BGO have secured a resolution to grant planning permission from Oxford City Council for Phase 2 of their development in the West End of Oxford. Known as Fabrica, the scheme will provide 180,000 sq ft of innovation real estate within a 10-minute walk from Oxford station and city centre. Designed by NBBJ, […]
Contractor 8build has secured the job to deliver the second phase of a 100,000 sq ft life sciences development in Cambridge. The Press biotech scheme is being developed by specialist investors Mission Street and BGO and will see lab and office space built either as a headquarters building or up to six smaller suites. This […]
